Resona Asset Management Co. Ltd. Takes $1.37 Million Position in Chemed Co. (NYSE:CHE)

Resona Asset Management Co. Ltd. bought a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,583 shares of the company's stock, valued at approximately $1,368,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CHE. Geode Capital Management LLC increased its stake in Chemed by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after acquiring an additional 4,966 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Chemed by 8.2% during the 4th quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after buying an additional 20,310 shares in the last quarter. Boston Trust Walden Corp lifted its position in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after buying an additional 22,105 shares during the last quarter. Norges Bank acquired a new stake in Chemed in the fourth quarter valued at about $95,872,000. Finally, Copeland Capital Management LLC grew its position in Chemed by 16.8% in the fourth quarter. Copeland Capital Management LLC now owns 151,623 shares of the company's stock valued at $80,330,000 after acquiring an additional 21,834 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CHE has been the topic of a number of research analyst reports. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada increased their price target on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research note on Friday, March 14th.

Remove Ads

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.32% of the stock is owned by corporate insiders.

Chemed Stock Down 1.6 %

NYSE CHE traded down $9.68 on Tuesday, hitting $591.01. The company's stock had a trading volume of 64,680 shares, compared to its average volume of 97,194. The firm has a market cap of $8.64 billion, a PE ratio of 29.86, a PEG ratio of 2.15 and a beta of 0.49. The company's 50-day moving average is $583.92 and its 200 day moving average is $567.73. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $625.09.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's payout ratio is 10.05%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.